Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Research and development activities to deliver immunology therapeutics for autoimmune and91.28M100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States91.28M100.00%